p benzoquinone Search Results


92
Thermo Fisher 2 6 di tert butyl p benzoquinone
2 6 Di Tert Butyl P Benzoquinone, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/2%2C6-Di-tert-butyl-p-benzoquinone%2C+98%25/pm39684087-69-22-32
Average 92 stars, based on 1 article reviews
2 6 di tert butyl p benzoquinone - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

86
Loba Chemie p benzoquinone
P Benzoquinone, supplied by Loba Chemie, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/benzoquinone+bq+p+para/10__1021_slash_acs__jpcc__9b10866____jp9b10866_si_001-0-56-58
Average 86 stars, based on 1 article reviews
p benzoquinone - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
Thermo Fisher p benzoquinone
P Benzoquinone, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/p-Benzoquinone%2C+98%2B%25/pm28948778-76-56-58
Average 94 stars, based on 1 article reviews
p benzoquinone - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
TLC Pharmaceutical Standards tramadol d6 hydrochloride
Parameters of MS method.
Tramadol D6 Hydrochloride, supplied by TLC Pharmaceutical Standards, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/Coenzyme+Q10-d6/pmc08779260-122-3-9
Average 93 stars, based on 1 article reviews
tramadol d6 hydrochloride - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Thermo Fisher 2 6 dimethyl p benzoquinone
Parameters of MS method.
2 6 Dimethyl P Benzoquinone, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/2%2C6-Dimethyl-p-benzoquinone%2C+99%25/pmc03680984-80-0-8
Average 91 stars, based on 1 article reviews
2 6 dimethyl p benzoquinone - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
Thermo Fisher tetrachloro p benzoquinone
Parameters of MS method.
Tetrachloro P Benzoquinone, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/Tetrachloro-p-benzoquinone%2C+99%25/us08633314-309-18-24
Average 90 stars, based on 1 article reviews
tetrachloro p benzoquinone - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Thermo Fisher phenyl benzoquinone
Parameters of MS method.
Phenyl Benzoquinone, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/Phenyl-p-benzoquinone%2C+95%25/pm17516648__ja071905gsi20070508_035616-108-33-34
Average 93 stars, based on 1 article reviews
phenyl benzoquinone - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Chem Impex International 2 3 dichloro 5 6 dicyano 1 4 benzoquinone ddq
Parameters of MS method.
2 3 Dichloro 5 6 Dicyano 1 4 Benzoquinone Ddq, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/2%2C3-Dichloro-5%2C6-dicyano-1%2C4-benzoquinone/pm32129617__ja9b13918_si_001-11-9-14
Average 95 stars, based on 1 article reviews
2 3 dichloro 5 6 dicyano 1 4 benzoquinone ddq - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Chem Impex International coenzyme q10
Parameters of MS method.
Coenzyme Q10, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/Coenzyme+Q10/pm33269585-221-1-9
Average 95 stars, based on 1 article reviews
coenzyme q10 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Szabo-Scandic HandelsgmbH & Co KG n acetyl p benzoquinone imine napqi
Effects of APAP, AM404 and <t>NAPQI</t> on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, <t>N-acetyl-p-benzoquinone</t> imine.
N Acetyl P Benzoquinone Imine Napqi, supplied by Szabo-Scandic HandelsgmbH & Co KG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/n+acetyl+p+benzoquinone+imine++napqi+/pmc06430418-28-54-58
Average 86 stars, based on 1 article reviews
n acetyl p benzoquinone imine napqi - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Shanghai Macklin Biochemical p benzoquinone
Effects of APAP, AM404 and <t>NAPQI</t> on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, <t>N-acetyl-p-benzoquinone</t> imine.
P Benzoquinone, supplied by Shanghai Macklin Biochemical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/benzoquinone+p/10__3390_slash_jfb16080304-43-73-75
Average 86 stars, based on 1 article reviews
p benzoquinone - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Merck KGaA p -benzoquinone
Kinetic plots depicting the oxidation of morin (0.1 mM) in the presence of HA-CuNPs (40 μg/mL) and H 2 O 2 (490 mM) in 10 mM carbonate buffer at pH 10 at 298 K without any radical scavengers (●), with 100 mM t -BuOH (⧫), 100 mM NaN 3 (■), and 100 mM p <t>-benzoquinone</t> (▲).
P Benzoquinone, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+benzoquinone/p+benzoquinone/pmc12004143-24-37-47
Average 90 stars, based on 1 article reviews
p -benzoquinone - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Parameters of MS method.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Parameters of MS method.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques:

The 90% confidence intervals for the stability calculated according to for ( a ) tramadol and ( b ) O-desmethyl-tramadol in human plasma stored at room temperature for 24 h and 72 h. Each sample size is associated with a different color, with light color indicating low concentration and dark color indicating high concentration. Vertical dashed lines indicate stability limits of 85–115%.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: The 90% confidence intervals for the stability calculated according to for ( a ) tramadol and ( b ) O-desmethyl-tramadol in human plasma stored at room temperature for 24 h and 72 h. Each sample size is associated with a different color, with light color indicating low concentration and dark color indicating high concentration. Vertical dashed lines indicate stability limits of 85–115%.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Descriptive statistics for the width [%] of a 90% confidence interval. The number of pairs is the equal number of reference and study samples.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Descriptive statistics for the width [%] of a 90% confidence interval. The number of pairs is the equal number of reference and study samples.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques:

Width of a 90% confidence interval for stability calculated according to for tramadol (full color) and O-desmethyl-tramadol (striped color) in human plasma stored at room temperature for 24 h and 72 h for each sample size: ( a ) low concentration, ( b ) high concentration.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Width of a 90% confidence interval for stability calculated according to for tramadol (full color) and O-desmethyl-tramadol (striped color) in human plasma stored at room temperature for 24 h and 72 h for each sample size: ( a ) low concentration, ( b ) high concentration.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Post-hoc least significant difference test (Fisher’s LSD test). Vertical bars means a 90% confidence interval: ( a ) tramadol; ( b ) O-desmethyl-tramadol. On each plot, light color indicates low concentration and dark color indicates high concentration.

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Post-hoc least significant difference test (Fisher’s LSD test). Vertical bars means a 90% confidence interval: ( a ) tramadol; ( b ) O-desmethyl-tramadol. On each plot, light color indicates low concentration and dark color indicates high concentration.

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Concentrations of  tramadol  in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 15.0 ng/mL) and high QC (nominal concentration of 600 ng/mL).

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Concentrations of tramadol in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 15.0 ng/mL) and high QC (nominal concentration of 600 ng/mL).

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Concentrations of O-desmethyl  tramadol  in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 7.50 ng/mL) and high QC (nominal concentration of 120 ng/mL).

Journal: Molecules

Article Title: Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

doi: 10.3390/molecules27020457

Figure Lengend Snippet: Concentrations of O-desmethyl tramadol in human plasma during stability testing after storage for 24 h and 72 h at room temperature—low QC (nominal concentration of 7.50 ng/mL) and high QC (nominal concentration of 120 ng/mL).

Article Snippet: O-desmethyl-tramadol-d6 (≤98%) and tramadol-d6 hydrochloride (≤99%) were purchased from TLC Pharmaceutical Standards (Newmarket, Ontario, Canada).

Techniques: Concentration Assay

Effects of APAP, AM404 and NAPQI on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, N-acetyl-p-benzoquinone imine.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: Effects of APAP, AM404 and NAPQI on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, N-acetyl-p-benzoquinone imine.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Injection

Effects of APAP, AM404, and NAPQI on currents through K V 7 channels in rat DRG and SDH neurons. Currents through K V 7 channels were recorded in perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. Baseline current levels in presence of solvent (DM, 0.1% DMSO in DRG neurons, 0.16% DMSO in SDH neurons) were recorded for 120 seconds, followed by application of paracetamol (APAP, AP, 100 μM), AM404 (AM, 10 μM), or NAPQI (NA, 10 μM) for 600 seconds. (A) A 180-second washout period followed the application of NAPQI; XE991 (3 μM) was applied for 180 seconds at the end of all recordings. All amplitudes were normalized to the average of the first 5 current amplitudes. (A) Displays representative K V 7 current traces in the presence of solvent (ctrl, black trace), NAPQI (NA, light gray trace), and XE991 (XE, dark gray trace) in DRG (left panel) and SDH (right panel) neurons. (B) Shows time courses of K V 7 currents normalized to the first control values in the presence of the respective compounds in DRG (left panel) and SDH (right panel) neurons indicated by the light gray-shaded area. Solvent (DMSO 0.1% for DRG and DMSO 0.16% for SDH neurons) was present in absence of the respective compounds. XE991 (3 µM) was applied for 180 seconds at the end of all recordings, indicated by the dark gray area, to verify the recording of currents through K V 7 channels. (C) Exhibits the statistical analysis of normalized K V 7 currents (fold change) after 600 seconds of application of the indicated compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA) in DRG (left panel) and SDH neurons (right panel). *Significant differences vs solvent (DM) at p < 0.05 (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: Effects of APAP, AM404, and NAPQI on currents through K V 7 channels in rat DRG and SDH neurons. Currents through K V 7 channels were recorded in perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. Baseline current levels in presence of solvent (DM, 0.1% DMSO in DRG neurons, 0.16% DMSO in SDH neurons) were recorded for 120 seconds, followed by application of paracetamol (APAP, AP, 100 μM), AM404 (AM, 10 μM), or NAPQI (NA, 10 μM) for 600 seconds. (A) A 180-second washout period followed the application of NAPQI; XE991 (3 μM) was applied for 180 seconds at the end of all recordings. All amplitudes were normalized to the average of the first 5 current amplitudes. (A) Displays representative K V 7 current traces in the presence of solvent (ctrl, black trace), NAPQI (NA, light gray trace), and XE991 (XE, dark gray trace) in DRG (left panel) and SDH (right panel) neurons. (B) Shows time courses of K V 7 currents normalized to the first control values in the presence of the respective compounds in DRG (left panel) and SDH (right panel) neurons indicated by the light gray-shaded area. Solvent (DMSO 0.1% for DRG and DMSO 0.16% for SDH neurons) was present in absence of the respective compounds. XE991 (3 µM) was applied for 180 seconds at the end of all recordings, indicated by the dark gray area, to verify the recording of currents through K V 7 channels. (C) Exhibits the statistical analysis of normalized K V 7 currents (fold change) after 600 seconds of application of the indicated compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA) in DRG (left panel) and SDH neurons (right panel). *Significant differences vs solvent (DM) at p < 0.05 (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Activity Assay

Effects of NAPQI on currents through native rat and recombinant human K V 7 channels. Currents through K V 7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset, and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. (A) Baseline was recorded in presence of solvent (0.1% DMSO in DRG neurons and tsA201 cells, or 0.16% DMSO in SDH neurons) for a period of 120 seconds, followed by different concentrations of NAPQI (0.1, 1, and 10 µM, as indicated) for 600 seconds, washout for 180 seconds and application of XE991 (3 μM) for 180 seconds. All amplitudes were normalized to the average of the first 5 current amplitudes in presence of the appropriate solvent. (A) Displays time courses of K V 7 currents, normalized to control values, and changes in the presence of NAPQI applied at concentrations of 0.1 μM (circles), 1 μM (squares), and 10 μM (triangles) as indicated by the gray-shaded area in DRG (top panel) and SDH (bottom panel) neurons. (B) Exhibits the statistical analysis of K V 7 currents, normalized to control values (fold change), at the end of a 600-second application of the indicated NAPQI concentration in DRG (top panel) and SDH (bottom panel) neurons. *, **Significant differences vs 10 µM NAPQI at P < 0.05 and P < 0.01, respectively. ns indicates no significant difference (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). (C) Shows time courses of currents through heteromeric human K V 7.2 and K V 7.3 (hKv7.2/7.3) channels expressed in tsA201 cells (left panel). Cells were perfused with solvent (0.1% DMSO, circles; n = 6) or NAPQI (1 µM, squares; n = 6) for 600 seconds, as indicated by the gray-shaded area. The right panel shows representative current traces in presence of solvent (0.1% DMSO, ctrl, black trace), NAPQI (1 µM, NA, light gray trace), or XE991 (3 µM, XE, dark gray trace). *Significant difference of normalized K V 7 current amplitudes: DMSO (0.91 ± 0.08) vs NAPQI 1 µM (1.29 ± 0.16) at p < 0.05 (Mann–Whitney test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: Effects of NAPQI on currents through native rat and recombinant human K V 7 channels. Currents through K V 7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset, and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. (A) Baseline was recorded in presence of solvent (0.1% DMSO in DRG neurons and tsA201 cells, or 0.16% DMSO in SDH neurons) for a period of 120 seconds, followed by different concentrations of NAPQI (0.1, 1, and 10 µM, as indicated) for 600 seconds, washout for 180 seconds and application of XE991 (3 μM) for 180 seconds. All amplitudes were normalized to the average of the first 5 current amplitudes in presence of the appropriate solvent. (A) Displays time courses of K V 7 currents, normalized to control values, and changes in the presence of NAPQI applied at concentrations of 0.1 μM (circles), 1 μM (squares), and 10 μM (triangles) as indicated by the gray-shaded area in DRG (top panel) and SDH (bottom panel) neurons. (B) Exhibits the statistical analysis of K V 7 currents, normalized to control values (fold change), at the end of a 600-second application of the indicated NAPQI concentration in DRG (top panel) and SDH (bottom panel) neurons. *, **Significant differences vs 10 µM NAPQI at P < 0.05 and P < 0.01, respectively. ns indicates no significant difference (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). (C) Shows time courses of currents through heteromeric human K V 7.2 and K V 7.3 (hKv7.2/7.3) channels expressed in tsA201 cells (left panel). Cells were perfused with solvent (0.1% DMSO, circles; n = 6) or NAPQI (1 µM, squares; n = 6) for 600 seconds, as indicated by the gray-shaded area. The right panel shows representative current traces in presence of solvent (0.1% DMSO, ctrl, black trace), NAPQI (1 µM, NA, light gray trace), or XE991 (3 µM, XE, dark gray trace). *Significant difference of normalized K V 7 current amplitudes: DMSO (0.91 ± 0.08) vs NAPQI 1 µM (1.29 ± 0.16) at p < 0.05 (Mann–Whitney test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Recombinant, Activity Assay, Concentration Assay, MANN-WHITNEY

Linopirdine blocks the NAPQI-induced reduction in excitability and hyperpolarization in rat DRG and SDH neurons. Membrane voltage and excitability were recorded in perforated current-clamp mode. Baseline values for membrane potential and excitability were determined during a 100-second application of solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons). This was followed by application of linopirdine alone (30 μM) for 150 seconds; the linopirdine-evoked depolarization was then compensated individually for each cell by current injection (indicated by the arrowhead in A) and a stable baseline was recorded for 150 seconds in the continuous presence of linopirdine. In DRG neurons, either NAPQI (1 µM) alone or in combination with the TRPV1 blocker AMG 9810 (100 nM) and the TRPA1 blocker HC 030031 (30 μΜ) was added for 600 seconds as indicated by the dark gray area. In SDH neurons, only NAPQI (1 µM) was present during the 600-second period indicated by the gray area. Membrane excitability was tested twice by injecting 5 equal increments of currents for a period of 2 seconds, once every 10 seconds, before and after the application of NAPQI for 600 seconds. (A) Shows time courses of changes in membrane voltage (left) in DRG (top) and SDH (bottom) neurons in the presence of linopirdine and with addition of NAPQI, either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons). (B) Shows the total number of action potentials in presence of linopirdine with compensated membrane potential before (adjusted, black circles) and at the end of a 600-second application of NAPQI (black triangles) either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons; p > 0.05 in each case, Wilcoxon matched-pairs signed rank test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: Linopirdine blocks the NAPQI-induced reduction in excitability and hyperpolarization in rat DRG and SDH neurons. Membrane voltage and excitability were recorded in perforated current-clamp mode. Baseline values for membrane potential and excitability were determined during a 100-second application of solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons). This was followed by application of linopirdine alone (30 μM) for 150 seconds; the linopirdine-evoked depolarization was then compensated individually for each cell by current injection (indicated by the arrowhead in A) and a stable baseline was recorded for 150 seconds in the continuous presence of linopirdine. In DRG neurons, either NAPQI (1 µM) alone or in combination with the TRPV1 blocker AMG 9810 (100 nM) and the TRPA1 blocker HC 030031 (30 μΜ) was added for 600 seconds as indicated by the dark gray area. In SDH neurons, only NAPQI (1 µM) was present during the 600-second period indicated by the gray area. Membrane excitability was tested twice by injecting 5 equal increments of currents for a period of 2 seconds, once every 10 seconds, before and after the application of NAPQI for 600 seconds. (A) Shows time courses of changes in membrane voltage (left) in DRG (top) and SDH (bottom) neurons in the presence of linopirdine and with addition of NAPQI, either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons). (B) Shows the total number of action potentials in presence of linopirdine with compensated membrane potential before (adjusted, black circles) and at the end of a 600-second application of NAPQI (black triangles) either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons; p > 0.05 in each case, Wilcoxon matched-pairs signed rank test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Injection

Application of NAPQI has no effect on synaptic activity in the rat spinal dorsal horn. Recordings were performed in lamina I neurons with monosynaptic C-fiber input in transversal spinal cord slices. (A) Shows original traces of C-fiber-eEPSCs recorded before and at the end of application of either NAPQI (NA) or NAPQI plus CNQX (NA + CN). (B) Displays the time course of normalized C-fiber-eEPSC amplitudes in lamina I neurons. Baseline was recorded for 150 seconds followed by application of NAPQI (10 µM) for 600 seconds (n = 7, p > 0.05 at the end of 600 seconds NAPQI compared with baseline). Bath application of CNQX (10 µM) blocked synaptic transmission at C-fiber synapses (n = 7, P < 0.05, one-way ANOVA at the end of 1200-second NAPQI + CNQX vs baseline). (C) Shows representative traces of sEPSCs at a holding potential of −70 mV before (top; ctrl), at the end of NAPQI application (middle), and at the end of NAPQI + CNQX (bottom). (D) Depicts the statistical analysis of the effects of NAPQI on amplitudes and frequencies of spontaneous EPSCs (sEPSCs) in the same lamina I neurons as in (B) determined at the end of 600-second NAPQI application (n = 7; p > 0.05 in both, one-sample t test). ANOVA, analysis of variance; NAPQI, N-acetyl-p-benzoquinone imine; sEPSCs, spontaneous excitatory postsynaptic currents.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: Application of NAPQI has no effect on synaptic activity in the rat spinal dorsal horn. Recordings were performed in lamina I neurons with monosynaptic C-fiber input in transversal spinal cord slices. (A) Shows original traces of C-fiber-eEPSCs recorded before and at the end of application of either NAPQI (NA) or NAPQI plus CNQX (NA + CN). (B) Displays the time course of normalized C-fiber-eEPSC amplitudes in lamina I neurons. Baseline was recorded for 150 seconds followed by application of NAPQI (10 µM) for 600 seconds (n = 7, p > 0.05 at the end of 600 seconds NAPQI compared with baseline). Bath application of CNQX (10 µM) blocked synaptic transmission at C-fiber synapses (n = 7, P < 0.05, one-way ANOVA at the end of 1200-second NAPQI + CNQX vs baseline). (C) Shows representative traces of sEPSCs at a holding potential of −70 mV before (top; ctrl), at the end of NAPQI application (middle), and at the end of NAPQI + CNQX (bottom). (D) Depicts the statistical analysis of the effects of NAPQI on amplitudes and frequencies of spontaneous EPSCs (sEPSCs) in the same lamina I neurons as in (B) determined at the end of 600-second NAPQI application (n = 7; p > 0.05 in both, one-sample t test). ANOVA, analysis of variance; NAPQI, N-acetyl-p-benzoquinone imine; sEPSCs, spontaneous excitatory postsynaptic currents.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Activity Assay, Transmission Assay

NAPQI abolishes bradykinin-mediated inhibition of currents through K V 7 channels in rat DRG neurons. Currents through K V 7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 15 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. (A) Shows a time course of normalized currents through K V 7 channels recorded in DRG neurons. Baseline current levels in presence of solvent (0.01% DMSO; DM) were recorded for 45 seconds followed by application of bradykinin (Bk, 10 nM) in the continued presence of solvent (empty circles and squares). Ninety seconds after the onset of Bk application, solvent was either replaced by NAPQI (NA, 1 µM, filled circles), or continuously coapplied together with bradykinin as indicated by the gray-shaded area. All amplitudes were normalized to the average of the first 4 current amplitudes in presence of solvent only. (B) Presents the statistical analysis of normalized K V 7 currents (fold change) after 210 seconds of co-application of either Bk + solvent or Bk + NAPQI. *Significant differences vs solvent at p < 0.05 (Mann–Whitney test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine.

Journal: Pain

Article Title: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on K V 7 channels

doi: 10.1097/j.pain.0000000000001474

Figure Lengend Snippet: NAPQI abolishes bradykinin-mediated inhibition of currents through K V 7 channels in rat DRG neurons. Currents through K V 7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 15 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of K V 7 channel activity. (A) Shows a time course of normalized currents through K V 7 channels recorded in DRG neurons. Baseline current levels in presence of solvent (0.01% DMSO; DM) were recorded for 45 seconds followed by application of bradykinin (Bk, 10 nM) in the continued presence of solvent (empty circles and squares). Ninety seconds after the onset of Bk application, solvent was either replaced by NAPQI (NA, 1 µM, filled circles), or continuously coapplied together with bradykinin as indicated by the gray-shaded area. All amplitudes were normalized to the average of the first 4 current amplitudes in presence of solvent only. (B) Presents the statistical analysis of normalized K V 7 currents (fold change) after 210 seconds of co-application of either Bk + solvent or Bk + NAPQI. *Significant differences vs solvent at p < 0.05 (Mann–Whitney test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine.

Article Snippet: N-(4-Hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide, N-(4-hydroxyphenyl) arachidonoylamide (AM404) was purchased from Enzo Biochem (New York), amphotericin B from PanReac AppliChem (Darmstadt, Germany), bradykinin, (2E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl) phenyl]-2-propenamide (AMG 9810), and 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl) acetamide (HC 030031) from Tocris Bioscience (Bristol, United Kingdom), cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) from Biotrend (Cologne, Germany) or Abcam (Cambridge, United Kingdom), linopirdine dihydrochloride from Hello Bio (Princeton), N-acetyl-p-benzoquinone imine (NAPQI) from Szabo-Scandic (Vienna, Austria), and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE991) was purchased from Alomone Labs (Jerusalem, Israel).

Techniques: Inhibition, Activity Assay, MANN-WHITNEY

Kinetic plots depicting the oxidation of morin (0.1 mM) in the presence of HA-CuNPs (40 μg/mL) and H 2 O 2 (490 mM) in 10 mM carbonate buffer at pH 10 at 298 K without any radical scavengers (●), with 100 mM t -BuOH (⧫), 100 mM NaN 3 (■), and 100 mM p -benzoquinone (▲).

Journal: ACS Omega

Article Title: Biocompatible Hyaluronic Acid-Stabilized Copper Nanoparticles for the Selective Oxidation of Morin Dye by H 2 O 2

doi: 10.1021/acsomega.5c00769

Figure Lengend Snippet: Kinetic plots depicting the oxidation of morin (0.1 mM) in the presence of HA-CuNPs (40 μg/mL) and H 2 O 2 (490 mM) in 10 mM carbonate buffer at pH 10 at 298 K without any radical scavengers (●), with 100 mM t -BuOH (⧫), 100 mM NaN 3 (■), and 100 mM p -benzoquinone (▲).

Article Snippet: Commercially available hyaluronic acid (low molecular weight around 30–50 kDa) (HA), morin hydrate, CuSO 4 ·5H 2 O, hydrogen peroxide (30%), Na 2 CO 3 , NaHCO 3 , HCl (32%), NaOH, t -BuOH, NaN 3 , p -benzoquinone, and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were all purchased from Merck KGaA and used as received.

Techniques: